Abiopharma

🔍 Richard Aurelie Pascale (Executive)

Company: MYR GROUP INC. (MYRG)

Report Date: 2026-04-23

Detailed Transactions and Holdings:

• Acquired 414 shares of RESTRICTED STOCK UNIT (Derivative)
  Date: 2026-04-23 | Code: A | equity_swap_involved: false | shares_owned_after: 414.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1

Footnotes:

• F1: Each Restricted Stock Unit, awarded pursuant to the Issuer's 2017 Long-Term Incentive Plan, represents a contingent right to receive one share of the Issuer's common stock. Restricted Stock Units will be converted into 414 shares of the Issuer's common stock on April 23, 2027.